Invite: Expert Access: Barclays Hosted: KOL Lunch at AAIC 2026 - Diving into CELIA Data and Other Alzheimer’s Updates

Research evidence excerpt

Invite: Expert Access: Barclays Hosted: KOL Lunch at AAIC 2026 - Diving into CELIA Data and Other Alzheimer’s Updates

•• Global Biopharma: Alzheimer's Disease KOL Call Prep Pack (06/11/26)

•• BIIB/LLY/BMY: Barclays Alzheimer's KOL Call: US takeaways (06/11/26)

Meet the Analysts

Emily Field, CFA is a Director and Head of U.S.

Biopharmaceuticals equity research at Barclays. Joining

the bank’s London office in 2017, she previously served as

Head of the European Pharmaceuticals team, earning a #4

individual ranking in European Pharmaceuticals &

Biotechnology in the 2025 Extel survey. With more than

two decades experience across both buy-side and sell-side

roles, she has worked across multiple investing strategies

including risk arbitrage and equity long/short. Prior to

Barclays, Ms. Field held positions at UBS O’Connor and

Millennium Management. Originally hailing from Chicago,

Ms. Field holds a B.A. in Economics and History from Yale

University, graduating with distinction in both majors, and

is a CFA charterholder.

View Analyst Page

U.S. Biopharmaceuticals

Emily Field, CFA

+1 212 526 4160

BCI, US

European Pharmaceuticals, Biotechnology & Life Sciences

James Gordon Charles Pitman-King, CFA

+44 (0)20 7116 2784 +44 (0)20 3134 6023

Barclays, UK Barclays, UK

This event is intended for Barclays institutional investor clients only. This event is strictly and solely

for the benefit of the intended recipients. Please do not forward this invitation to any other party

without written consent from Barclays Research. Barclays' Investment Bankers are prohibited from

attending this event. Participant comments are not for attribution.

If your firm is in-scope for research unbundling under MiFID II and you require further information